Antimicrobial Resistance Diagnostics Market Report 2026
Antimicrobial Resistance Diagnostics Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Antimicrobial Resistance Diagnostics Market Report 2026

Global Outlook – By Product Type (Kits And Reagents, Instruments And Consumables), By Pathogen (Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens), By Technology (Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies), By End-User (Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Antimicrobial Resistance Diagnostics Market Overview

• Antimicrobial Resistance Diagnostics market size has reached to $4.41 billion in 2025

• Expected to grow to $6.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%

• Growth Driver: Rising Drug-Resistant Infections Driving The Growth Of The Market Due To The Need For Early Detection And Targeted Treatment

• Market Trend: Technological Advancement In Rapid Point-Of-Care Diagnostics

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antimicrobial Resistance Diagnostics Market?

Antimicrobial resistance (AMR) diagnostics are tests used to detect the presence of microorganisms that have developed resistance to antibiotics or other antimicrobial agents. These diagnostics help identify the specific pathogen and determine which drugs it is resistant or susceptible to, enabling targeted and effective treatment. Antimicrobial resistance (AMR) diagnostics are essential for controlling the spread of resistant infections and guiding appropriate antimicrobial use in both clinical and public health settings.

The main product types in the antimicrobial resistance diagnostics market include kits and reagents, instruments, and consumables. Kits and reagents are standardized sets of chemicals and biological materials used to detect or measure specific pathogens or substances in diagnostic tests. These diagnostics are used to detect various pathogens such as drug-resistant Streptococcus pneumoniae (DRSP), drug-resistant Campylobacter (DRC), Clostridium difficile (CD), methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant Neisseria gonorrhoeae (DRNG), drug-resistant Salmonella (DRNTS), and other resistant pathogens. A range of technologies is employed, including microbiology culture, immunoassay, polymerase chain reaction (PCR), next-generation sequencing (NGS), mass spectrometry, rapid and point-of-care testing, and others. The key end-users are hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others.

Antimicrobial Resistance Diagnostics market report bar graph

What Is The Antimicrobial Resistance Diagnostics Market Size and Share 2026?

The antimicrobial resistance diagnostics market size has grown strongly in recent years. It will grow from $4.41 billion in 2025 to $4.74 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of antibiotic-resistant infections, reliance on conventional culture-based diagnostics, rising hospital-acquired infections, growing awareness of antimicrobial stewardship, expansion of clinical microbiology laboratories.

What Is The Antimicrobial Resistance Diagnostics Market Growth Forecast?

The antimicrobial resistance diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to advancement in pcr and ngs diagnostic technologies, increasing government funding for amr surveillance programs, rising adoption of rapid diagnostic tests, growth in pharmaceutical and biotechnology research, integration of data-driven decision support tools. Major trends in the forecast period include rising adoption of rapid and point-of-care amr diagnostics, growing demand for targeted and personalized antimicrobial therapy, increased surveillance of drug-resistant pathogens, expansion of molecular and genomic-based diagnostic testing, strengthening of hospital infection control and stewardship programs.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Antimicrobial Resistance Diagnostics Market Segmentation

1) By Product Type: Kits And Reagents, Instruments And Consumables

2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens

3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies

4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media

2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs

What Is The Driver Of The Antimicrobial Resistance Diagnostics Market?

The rising prevalence of drug-resistant infections is expected to propel the growth of the antimicrobial resistance diagnostics market going forward. Drug-resistant infections occur when bacteria, viruses, fungi, or parasites evolve mechanisms to survive exposure to medications that were previously effective against them, making standard treatments ineffective and infections harder to control. The growing prevalence of drug-resistant infections is due to the overuse of antibiotics in agriculture, where low-dose antimicrobials are routinely added to animal feed, promoting resistance that can spread to humans through the food chain. Antimicrobial resistance diagnostics, such as rapid genetic assays and culture-based sensitivity tests, play a pivotal role in combating the growing prevalence of drug-resistant infections by enabling early identification of resistant pathogens, guiding targeted therapies, and reducing the misuse of broad-spectrum antibiotics. For instance, in November 2024, according to the UK Health Security Agency (UKHSA), a UK-based government agency, the agency reported that the number of serious antibiotic-resistant infections in England rose from 58,224 in 2022 to an estimated 66,730 in 2023, while antibiotic use increased to 2.4% in 2023 from 2022. Therefore, the rising prevalence of drug-resistant infections is driving the growth of the antimicrobial resistance diagnostics industry.

Key Players In The Global Antimicrobial Resistance Diagnostics Market

Major companies operating in the antimicrobial resistance diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc

Global Antimicrobial Resistance Diagnostics Market Trends and Insights

Major companies operating in the antimicrobial resistance (AMR) diagnostics market are focusing on leveraging innovative technologies such as point-of-care antimicrobial-susceptibility testing (AST) technologies to enhance diagnostic speed, precision, and antimicrobial-stewardship outcomes. Point-of-care antimicrobial-susceptibility testing (AST) refers to rapid, near-patient tests that identify which antibiotics will work against an infection, helping clinicians choose effective, targeted treatment quickly. For instance, in June 2023, Sysmex Corporation, a Japan-based provider of in-vitro diagnostic solutions, launched the PA-100 AST System, a point-of-care rapid AST platform designed to detect bacterial presence and determine antimicrobial susceptibility in urine samples within approximately 30 minutes. The system features microfluidic single-cell analysis, near-patient testing capability, and automated reporting of susceptibility outcomes. The PA-100 AST System improves clinical decision-making, reduces unnecessary antibiotic prescription, and supports timely, targeted therapy to combat antimicrobial resistance.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Antimicrobial Resistance Diagnostics Market?

In June 2025, bioMérieux, a France-based provider of in vitro diagnostic (IVD) solutions and infectious disease testing technologies, acquired the assets of Day Zero Diagnostics for an undisclosed amount. With this acquisition, bioMérieux gains access to Day Zero Diagnostics’ next-generation sequencing (NGS) workflows, NGS chemistries, bioinformatics pipeline, and artificial intelligence (AI)-driven antimicrobial resistance (AMR) prediction technologies, thereby strengthening its next-generation antimicrobial resistance diagnostics capabilities while enhancing its innovation pipeline in rapid pathogen identification and antimicrobial susceptibility testing (AST). Day Zero Diagnostics is a US–based developer of sequencing-based infectious disease diagnostic technologies.

Regional Outlook

North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Antimicrobial Resistance Diagnostics Market?

The antimicrobial resistance diagnostics market consists of revenues earned by entities by providing services such as pathogen identification, resistance gene detection, rapid screening, antimicrobial susceptibility testing, and diagnostic data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance diagnostics market includes sales of polymerase chain reaction (PCR) instruments, immunoassay kits, point-of-care testing devices, sequencing reagents, and microbiology culture consumables. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antimicrobial Resistance Diagnostics Market Report 2026?

The antimicrobial resistance diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Antimicrobial Resistance Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.74 billion
Revenue Forecast In 2035 $6.23 billion
Growth Rate CAGR of 7.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Pathogen, Technology, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Antimicrobial Resistance Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Antimicrobial Resistance Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Antimicrobial Resistance Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Antimicrobial Resistance Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Rapid And Point-Of-Care Amr Diagnostics

4.2.2 Growing Demand For Targeted And Personalized Antimicrobial Therapy

4.2.3 Increased Surveillance Of Drug-Resistant Pathogens

4.2.4 Expansion Of Molecular And Genomic-Based Diagnostic Testing

4.2.5 Strengthening Of Hospital Infection Control And Stewardship Programs

5. Antimicrobial Resistance Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostics Laboratories

5.3 Research Institutes

5.4 Pharmaceutical And Biotechnology Companies

5.5 Public Health And Surveillance Agencies

6. Antimicrobial Resistance Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Antimicrobial Resistance Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Antimicrobial Resistance Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Antimicrobial Resistance Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Antimicrobial Resistance Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Antimicrobial Resistance Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Antimicrobial Resistance Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Antimicrobial Resistance Diagnostics Market Segmentation

9.1. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Kits And Reagents, Instruments And Consumables

9.2. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens

9.3. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies

9.4. Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

9.5. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media

9.6. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs

10. Antimicrobial Resistance Diagnostics Market Regional And Country Analysis

10.1. Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Antimicrobial Resistance Diagnostics Market

11.1. Asia-Pacific Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Antimicrobial Resistance Diagnostics Market

12.1. China Antimicrobial Resistance Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Antimicrobial Resistance Diagnostics Market

13.1. India Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Antimicrobial Resistance Diagnostics Market

14.1. Japan Antimicrobial Resistance Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Antimicrobial Resistance Diagnostics Market

15.1. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Antimicrobial Resistance Diagnostics Market

16.1. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Antimicrobial Resistance Diagnostics Market

17.1. South Korea Antimicrobial Resistance Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Antimicrobial Resistance Diagnostics Market

18.1. Taiwan Antimicrobial Resistance Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Antimicrobial Resistance Diagnostics Market

19.1. South East Asia Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Antimicrobial Resistance Diagnostics Market

20.1. Western Europe Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Antimicrobial Resistance Diagnostics Market

21.1. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Antimicrobial Resistance Diagnostics Market

22.1. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Antimicrobial Resistance Diagnostics Market

23.1. France Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Antimicrobial Resistance Diagnostics Market

24.1. Italy Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Antimicrobial Resistance Diagnostics Market

25.1. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Antimicrobial Resistance Diagnostics Market

26.1. Eastern Europe Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Antimicrobial Resistance Diagnostics Market

27.1. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Antimicrobial Resistance Diagnostics Market

28.1. North America Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Antimicrobial Resistance Diagnostics Market

29.1. USA Antimicrobial Resistance Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Antimicrobial Resistance Diagnostics Market

30.1. Canada Antimicrobial Resistance Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Antimicrobial Resistance Diagnostics Market

31.1. South America Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Antimicrobial Resistance Diagnostics Market

32.1. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Antimicrobial Resistance Diagnostics Market

33.1. Middle East Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Antimicrobial Resistance Diagnostics Market

34.1. Africa Antimicrobial Resistance Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Antimicrobial Resistance Diagnostics Market Regulatory and Investment Landscape

36. Antimicrobial Resistance Diagnostics Market Competitive Landscape And Company Profiles

36.1. Antimicrobial Resistance Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Antimicrobial Resistance Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Antimicrobial Resistance Diagnostics Market Company Profiles

36.3.1. F Hoffmann La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

37. Antimicrobial Resistance Diagnostics Market Other Major And Innovative Companies

bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid

38. Global Antimicrobial Resistance Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Antimicrobial Resistance Diagnostics Market

40. Antimicrobial Resistance Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Antimicrobial Resistance Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Antimicrobial Resistance Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Antimicrobial Resistance Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Antimicrobial Resistance Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Antimicrobial Resistance Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Antimicrobial Resistance Diagnostics Market, Supply Chain Analysis
  • Table 4: Global Antimicrobial Resistance Diagnostics Market, Major Raw Material Providers
  • Table 5: Global Antimicrobial Resistance Diagnostics Market, Major Resource Providers
  • Table 6: Global Antimicrobial Resistance Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Antimicrobial Resistance Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global Antimicrobial Resistance Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global Antimicrobial Resistance Diagnostics Market, Major Trends
  • Table 10: Global Antimicrobial Resistance Diagnostics Market, Major End Users
  • Table 11: Global Antimicrobial Resistance Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Antimicrobial Resistance Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Antimicrobial Resistance Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Antimicrobial Resistance Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Antimicrobial Resistance Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Antimicrobial Resistance Diagnostics Market - Company Scoring Matrix
  • Table 97: F Hoffmann La Roche AG Financial Performance
  • Table 98: Thermo Fisher Scientific Inc Financial Performance
  • Table 99: Abbott Laboratories Financial Performance
  • Table 100: Danaher Corporation Financial Performance
  • Table 101: Becton Dickinson And Company Financial Performance
  • Table 102: Global Antimicrobial Resistance Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Antimicrobial Resistance Diagnostics Market, Competitive Dashboard
  • Table 104: Global Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 106: Global, Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), Segmentation By Pathogen, 2025 – 2030
  • Table 107: Global, Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

    Figure 1: Global Antimicrobial Resistance Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Antimicrobial Resistance Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Antimicrobial Resistance Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global Antimicrobial Resistance Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global Antimicrobial Resistance Diagnostics Market, Major Resource Providers
  • Figure 6: Global Antimicrobial Resistance Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Antimicrobial Resistance Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global Antimicrobial Resistance Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global Antimicrobial Resistance Diagnostics Market, Major Trends
  • Figure 10: Global Antimicrobial Resistance Diagnostics Market, Major End Users
  • Figure 11: Global Antimicrobial Resistance Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Antimicrobial Resistance Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Antimicrobial Resistance Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Antimicrobial Resistance Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Antimicrobial Resistance Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Antimicrobial Resistance Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Antimicrobial Resistance Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Antimicrobial Resistance Diagnostics Market - Company Scoring Matrix
  • Figure 97: F Hoffmann La Roche AG Financial Performance
  • Figure 98: Thermo Fisher Scientific Inc Financial Performance
  • Figure 99: Abbott Laboratories Financial Performance
  • Figure 100: Danaher Corporation Financial Performance
  • Figure 101: Becton Dickinson And Company Financial Performance
  • Figure 102: Global Antimicrobial Resistance Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Antimicrobial Resistance Diagnostics Market, Competitive Dashboard
  • Figure 104: Global Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 106: Global, Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), Segmentation By Pathogen, 2025 – 2030
  • Figure 107: Global, Antimicrobial Resistance Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Frequently Asked Questions

The Antimicrobial Resistance Diagnostics market was valued at $4.41 billion in 2025, increased to $4.74 billion in 2026, and is projected to reach $6.23 billion by 2030.

The global Antimicrobial Resistance Diagnostics market is expected to grow at a CAGR of 7.1% from 2026 to 2035 to reach $6.23 billion by 2035.

Some Key Players in the Antimicrobial Resistance Diagnostics market Include, F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc .

Major trend in this market includes: Technological Advancement In Rapid Point-Of-Care Diagnostics. For further insights on this market. request a sample here

North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts